Greg Wolf to Interferon Type I
This is a "connection" page, showing publications Greg Wolf has written about Interferon Type I.
Connection Strength
0.234
-
Gong W, Taner HF, Wu Y, He Y, Zhou X, Li Z, Hu X, Ursin C, Debnath KC, Okuyama K, Hu Q, Donnelly CR, N?r F, Perera CD, Bellile E, Yunesi A, Zhai Z, Zhao M, Cheng W, Fitzsimonds ZR, Broses L, Li J, Demehri S, Nagrath D, Wolf GT, Sikora AG, Yu Y, Wen H, Wei L, Chinn SB, Myers JN, Akira S, Xie Y, Moon JJ, Lei YL. BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity. Nat Commun. 2025 Dec 29; 17(1):1271.
Score: 0.204
-
Tan YS, Sansanaphongpricha K, Xie Y, Donnelly CR, Luo X, Heath BR, Zhao X, Bellile E, Hu H, Chen H, Polverini PJ, Chen Q, Young S, Carey TE, N?r JE, Ferris RL, Wolf GT, Sun D, Lei YL. Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine. Clin Cancer Res. 2018 09 01; 24(17):4242-4255.
Score: 0.030